CMS is an open platform enterprise that links pharmaceutical innovation and commercialization, controls product life cycle management, and is committed to providing competitive products and services to meet unmet medical needs. Kang Zhe Pharmaceutical Co., Ltd. focuses on the innovative products of the global initiative (FIC) and the best of its kind (BIC). It has a rich innovation pipeline with differentiated layout, high innovation level and great market potential. Kangzhe Pharmaceutical Co., Ltd. focuses on the specialist field, has proven commercialization capabilities, extensive channel network and expert resources, and the core products on sale have gained a leading academic and market position. Focus on the in-depth development of superior specialist areas, expand the boundary, in order to consolidate the competitiveness of cardio-cerebrovascular / digestive business, and operate the skin and ophthalmology business independently to improve scale efficiency. At the same time, the business territory is expanded to the Southeast Asian market, making great efforts to become the "bridgehead" for global pharmaceutical companies to enter the Southeast Asian market, and to promote the high-quality, sustained and healthy development of Kangzhe Pharmaceutical Industry.
No Data